T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$2.31B |
| 2 |
Apple
AAPL
|
+$1.58B |
| 3 |
Sherwin-Williams
SHW
|
+$1.37B |
| 4 |
HubSpot
HUBS
|
+$1.32B |
| 5 |
Kenvue
KVUE
|
+$1.25B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.37B |
| 2 |
Lam Research
LRCX
|
+$1.54B |
| 3 |
Applied Materials
AMAT
|
+$1.33B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.19B |
| 5 |
Halliburton
HAL
|
+$1.16B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.32% |
| 2 | Healthcare | 15.15% |
| 3 | Financials | 10.54% |
| 4 | Consumer Discretionary | 10.48% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Strategy Inc
MSTR
$38.2B
| $37.9M | ﹤0.01% |
224,969
-59,211
| -21% | -$8.47M |
|
827
BioNTech
BNTX
$23.1B
| $37.9M | ﹤0.01% |
318,869
+266,667
| +511% | +$24.5M |
|
828
Hewlett Packard
HPE
$79.2B
| $37.4M | ﹤0.01% |
1,829,011
-1,367,170
| -43% | -$26.1M |
|
829
Relay Therapeutics
RLAY
$4.37B
| $37.4M | ﹤0.01% |
5,280,291
+241,276
| +5% | +$1.8M |
|
830
Trex
TREX
$5.1B
| $37M | ﹤0.01% |
556,115
-52,054
| -9% | -$3.65M |
|
831
Valvoline
VVV
$4.31B
| $37M | ﹤0.01% |
883,469
+252,668
| +40% | +$10.7M |
|
832
Olin
OLN
$2.17B
| $36.8M | ﹤0.01% |
767,013
-20,571
| -3% | -$915K |
|
833
Sterling Infrastructure
STRL
$16.9B
| $36.6M | ﹤0.01% |
252,697
+1,793
| +0.7% | +$213K |
|
834
CNX Resources
CNX
$5.23B
| $36.6M | ﹤0.01% |
1,125,121
+144,877
| +15% | +$3.9M |
|
835
Blackbaud
BLKB
$2.1B
| $36.6M | ﹤0.01% |
432,393
+13,745
| +3% | +$1.09M |
|
836
Bruker
BRKR
$8.83B
| $36.6M | ﹤0.01% |
529,646
-244,658
| -32% | -$15.8M |
|
837
Donnelley Financial Solutions
DFIN
$1.22B
| $36.6M | ﹤0.01% |
555,364
+43,974
| +9% | +$2.85M |
|
838
RLI Corp
RLI
$5.87B
| $36.5M | ﹤0.01% |
470,830
-82,786
| -15% | -$6.12M |
|
839
Beam Therapeutics
BEAM
$2.74B
| $36.4M | ﹤0.01% |
1,486,308
+92,635
| +7% | +$2.39M |
|
840
NovoCure
NVCR
$2.02B
| $36.3M | ﹤0.01% |
2,322,196
+166,175
| +8% | +$3.01M |
|
841
Church & Dwight Co
CHD
$24B
| $36.3M | ﹤0.01% |
346,413
-51,627
| -13% | -$5.3M |
|
842
UFP Technologies
UFPT
$2.48B
| $36.3M | ﹤0.01% |
114,512
+7,678
| +7% | +$2.45M |
|
843
Federal Realty Investment Trust
FRT
$10.3B
| $36.2M | ﹤0.01% |
314,819
-1,843
| -0.6% | -$206K |
|
844
Ivanhoe Electric
IE
$1.66B
| $36M | ﹤0.01% |
4,253,602
-2,430,794
| -36% | -$20.4M |
|
845
T. Rowe Price Blue Chip Growth ETF
TCHP
$2.22B
| $35.7M | ﹤0.01% |
900,001
+250,000
| +38% | +$9.58M |
|
|
DAWN
846
DELISTED
Day One Biopharmaceuticals
DAWN
| $35.5M | ﹤0.01% |
2,544,863
+193,983
| +8% | +$2.77M |
|
847
Group 1 Automotive
GPI
$3.14B
| $35.2M | ﹤0.01% |
91,906
+6,248
| +7% | +$2.15M |
|
848
SM Energy
SM
$7.71B
| $35.1M | ﹤0.01% |
878,134
-22,865
| -3% | -$992K |
|
849
Zoom
ZM
$32.2B
| $35.1M | ﹤0.01% |
503,047
+337,103
| +203% | +$21.1M |
|
850
Champion Homes
SKY
$5.23B
| $35M | ﹤0.01% |
369,128
-5,962
| -2% | -$500K |
|
Similar funds
T. Rowe Price Associates's Q3 2024 Portfolio in Review
As of Q3 2024, T. Rowe Price Associates held 3,059 positions worth $869B, up 3.9% from $836B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 4.3%. T. Rowe Price Associates opened 82 new positions and exited 51, leaving the 3,059-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2024 buy was Lineage Inc: 4,699,854 shares worth $368M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q3 2024, an estimated $2.31B increase.
- T. Rowe Price Associates's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $4.37B.
- T. Rowe Price Associates fully exited Morphic Holding, Inc. Common Stock in Q3 2024, selling an estimated $75.2M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $869B portfolio in Q3 2024.
- T. Rowe Price Associates opened 82 new positions and closed 51 in Q3 2024.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $869B.
Based on T. Rowe Price Associates's 13F filing for Q3 2024, filed 14 Nov 2024.